11th Pharma Pricing, Reimbursement & Market Access 2027

The 11th Pharma Pricing, Reimbursement & Market Access 2027 is a conference dedicated to an overview of global pricing, market access systems and cost management techniques.

Key Topics

• US policy challenges for market access: Stepping ahead, especially during this Covid19
• Formulating your best market access strategy during the pandemic
• Unrivalled opportunity to expose and address the market access challenges facing the industry
• How to capture and quantify patient value?
• Current & future - Challenges & opportunities in pharma pricing, reimbursement & market access
• The role of Real World Evidence (RWE) in Oncology
• Measurement strategies through to in-depth knowledge regarding payer formulary coverage trends
• Improving patient and market access through the development of targeted value propositions, comprehensive contract assessment
• Understanding - payers’ perspective
• How can payers and industry work together to ensure that innovative and valuable treatments make it to the market?
• Creating a robust patient services and reimbursement support program for biosimilar products
• Advocating and collaborating with payers for value in a new era
• Understand how price affects market access and learn on how to set prices for optimal access and returns.
• Prioritising Patients! - Adding value through an innovative patient-centered approach
• Evidence Generation - The strategic rigor and creativity applied to evidence generation
• New drugs are failing to gain reimbursement from payers/HTAs at an alarming rate, despite being approved by regulators
• Developing risk-sharing reimbursement models and value based pricing
• Impact of social media and digital analytics
• Explaining how to use the data sources and observational research for effective safety analysis
• Patient engagement and adherence within the environment
• Be part of a major networking opportunity
• Dwell ahead of regulatory developments & improving your strategies in a cost effective way Accelerating new medicine introduction in developing world & overcoming challenges